Dengue case investigation report (Haiti travel) by National Center for Zoonotic, Vector-Borne and Enteric Diseases (U.S.). Division of Vector Borne Infectious Diseases. Dengue Branch. & Puerto Rico. Department of Health.
Warning signs Yes       No           Unk   
Persistent vomiting...................................
Abdominal pain/Tenderness…………..
Mucosal bleeding …………………….....
Lethargy, restlessness……….…………...
Liver enlargement >2cm………………..
Pleural or abdominal effusion………….
Additional symptoms
Diarrhea……………………………...……..
Cough…………………………………….…
Conjunctivitis……………………………....
Nasal congestion………………………… 
Sore throat……………………………….... 
Jaundice………………………..................
Convulsion or coma……………………..
Nausea and vomiting (occasional)….. 
Arthritis (Swollen joints)……....................
Yes          No            Unk
Fever lasting 2-7 days……………......
Fever now(>38ºC)…………………......
Platelets ≤100,000/mm3………..….....
Platelet count:  ______________________________
Any hemorrhagic manifestation
Petechiae………………………..
Purpura/Ecchymosis…………..
Vomit with blood……………….
Blood in stool……………………
Nasal bleeding…………………
Bleeding gums………………….
Blood in urine…………………...
Vaginal bleeding………………
Positive urinalysis……………....
(over 5 RBC/hpf or positive for blood)
Tourniquet test Pos           Neg           Not done 
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Evidence of capillary leak
Lowest hematocrit (%)   __________________
Highest hematocrit (%)  __________________
Lowest serum albumin   __________________
Lowest serum protein     __________________
Lowest blood pressure (SBP/DBP)    __________/_______
Lowest pulse pressure (systolic - diastolic)    _________
Lowest white blood cell count (WBC)             _________
Name  (complete)
Relationship with patient:
Tel:                                            Fax:                                             Email:
Physician who referred this case 
Name of Healthcare Provider:
Tel:                                     Fax:                                      Email:
Send laboratory results to (mailing address):
PLEASE indicate below the signs and symptoms that the patient has at the time that this form is being completed
Specimen # Days post onset (DPO) Type Date Received
S1 _____/_____/_____
S2 _____/_____/_____
Specimen # Days post onset (DPO) Type Date Received
S3 _____/_____/_____ 
S4 _____/_____/_____
Case number
GCODESAN ID
City:                                                              Zip code: __ __ __ __ __ - __ __ __ __
Tel:                                                  Other Tel:
Residence is close to:
Work address:
Home (Physical) Address
Day   Month          Year
Date of first symptom: _______/_______/_______
Date specimen taken:
Serum: First sample _______/_______/_______
(Acute = first 5 days of illness – check for virus)
Second sample _______/_______/_______
(Convalescent = more than 5 days after onset – check  for antibodies)
Third sample _______/_______/_______
Fatal cases (tissue type):_______________________ _______/_______/_______
Must have the following information for sample processing
Please read and complete ALL sections
Hospitalized due to this illness:  No        Yes → Hospital Name:
Name of Patient:
If patient is a minor, name of father or primary caregiver:
Last Name First Name Middle Name or Initial
Last Name First Name Middle Name or Initial
Fatal:
Yes No Unk
Mental status changes:
Yes No Unk
Date of Birth: Age: month   Sex:           M F
_______/_______/_______   or Age: years    Pregnant:   Y     N     UNK
Weeks pregnant (gestation):  
Patient’s Demographic Information
Symptoms Yes         No       Unk                    
Rapid, weak pulse……………...
Pallor or cool skin……………….
Chills………………………….……
Rash…...........................................
Headache……………….……….
Eye pain…………………………..
Body (muscle/bone) pain…….
Joint pain…………………………
Anorexia……………………….....
How long have you lived in this city?
Country of birth
Have you been diagnosed with dengue before? Yes No Unk
When diagnosed? _______/_______                Unk
Month          Year
Got Yellow Fever Vaccine           Yes          No        Unk    Year vaccinated  
During the 14 days before onset of illness, did you TRAVEL to other cities or countries?
Yes, another country               Yes, another city         No Unk
WHERE did you TRAVEL? _____________________________________________________________
Day Month Year
Ho
m
e 
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dr
es
s 
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re
Patient Data
Today’s date:  _______/_______/_______
Day      Month     Year  
Civilian:                DoD: 
Who filled out this form?
Additional Patient Data
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Specimen No.
S1 _________________________________ S2 _________________________________ S3 _________________________________
SEROLOGY
LUMINEX (MIA)
S1 S2 S3
Test Date Ag Titer Test Date Ag Titer Test Date Ag Titer
IgG ELISA
S1 S2 S3
Test Date Ag Screen Titer Test Date Ag Screen Titer Test Date Ag Screen Titer
IgM ELISA
S1 S2 S3
Neutralization
S1 S2 S3
Test Date Screen Titer Test Date Screen Titer Test Date Screen Titer
DENV-1
DENV-2
DENV-3
DENV-4
WEST NILE
SLE
YFV
Viral Isolation & PCR
S1 S2 S3
Test Date                                  ID Isotech IDtech Test Date                 ID Isotech IDtech Test Date ID Isotech IDtech
This questionnaire is authorized by law (Public Health Service Act 42 USC 241). Although response to the questions asked is voluntary, cooperation of the patient is necessary for the study and 
control of the disease. Public reporting burden for the collection of information is estimated to average 15 minutes per response. Send comments regarding this burden estimate or any other 
aspect of this collection of information, including suggestions for reducing the burden to PHS Reports Clearance Officer; Rm. 721-H, Humphrey Bg; 200 Independence Ave., SW;  Washington, DC 
20201; ATTN: PRA, and to the Office of information and Regulatory Affaire, Office of Management and Budget, Washington, DC.
CS110856
Virology Lab Director Signature: ______________________________________   Overall dengue interpretation: _________________________________
Serology Lab Director Signature: ______________________________________
Test Date Ag P/N Test Date Ag P/N Test Date Ag P/N
